The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> August 12, 2016

Interview with the CFO: Ignyta, Inc. (NASDAQ:RXDX)

Chacko, Jacob
Jacob Chacko, M.D. is Chief Financial Officer at Ignyta, Inc. Dr. Chacko brings to the company a broad range of experience with financing, managing and advising companies in the life sciences field. Dr. Chacko joined Ignyta, Inc. in May 2014 from TPG Capital, a global private investment firm with approximately $60 billion of assets under management, where he served as a Vice President focused primarily on health care and digital media since August 2008. At TPG Capital, Dr. Chacko helped lead teams that successfully completed acquisitions having an aggregate value of over $10 billion. He served on the boards of directors of RentPath and EnvisionRx, was an adviser to the audit committee of Par Pharmaceutical and was a board observer to IMS Health and Quintiles Transnational. Dr. Chacko currently serves on the board of the Packard Children’s Health Alliance at the Lucile Packard Children’s Hospital Stanford and on the Western Regional Selection Committee for the Marshall Scholarship. Prior to TPG Capital, Dr. Chacko concurrently received his M.D. with AOA honors from UCLA and his MBA with distinction from Harvard Business School, and was president of his class at both institutions. Prior to this, Dr. Chacko was a Consultant serving health care clients at the management consulting firm McKinsey & Company. Dr. Chacko received a M.Sc. in economic and social history from Oxford University, where he was a Marshall Scholar, and a B.A. in biology, B.S. in gerontology, and minor in health policy and management from the University of Southern California as University Valedictorian. Profile
TWST: Can you describe Ignyta today and its business model?

Dr. Chacko: Ignyta is a San Diego-based biotech company focused on precision medicine in oncology. Some

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
Interview with the Co-CEO and the CAO: Planet 13 Holdings Inc. (OTCMKTS:PLNH)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy